Glimepiride
- Product NDC
- 42571-105
- 11-digit product format
- 425710105
- Labeler code
- 42571
- Product ID
- 42571-105_34e9a6b6-450b-7d20-e063-6294a90ac831
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glimepiride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Micro Labs Limited
- Application
- ANDA091220
- Marketing category
- ANDA
- Marketing start
- 2013-06-13
- Substance
- GLIMEPIRIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091220-001 | GLIMEPIRIDE | GLIMEPIRIDE | 1MG | TABLET / ORAL | AB | 2012-06-29 | |
| A091220-002 | GLIMEPIRIDE | GLIMEPIRIDE | 2MG | TABLET / ORAL | AB | 2012-06-29 | |
| A091220-003 | GLIMEPIRIDE | GLIMEPIRIDE | 3MG | TABLET / ORAL | 2012-06-29 | ||
| A091220-004 | GLIMEPIRIDE | GLIMEPIRIDE | 4MG | TABLET / ORAL | AB | 2012-06-29 | |
| A091220-005 | GLIMEPIRIDE | GLIMEPIRIDE | 6MG | TABLET / ORAL | 2012-06-29 | ||
| A091220-006 | GLIMEPIRIDE | GLIMEPIRIDE | 8MG | TABLET / ORAL | AB | 2012-06-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091220-001 | AB |
| A091220-002 | AB |
| A091220-004 | AB |
| A091220-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091220-001 | GLIMEPIRIDE | 1MG | TABLET / ORAL | AB | 2012-06-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091220-002 | GLIMEPIRIDE | 2MG | TABLET / ORAL | AB | 2012-06-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091220-003 | GLIMEPIRIDE | 3MG | TABLET / ORAL | 2012-06-29 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A091220-004 | GLIMEPIRIDE | 4MG | TABLET / ORAL | AB | 2012-06-29 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091220-005 | GLIMEPIRIDE | 6MG | TABLET / ORAL | 2012-06-29 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A091220-006 | GLIMEPIRIDE | 8MG | TABLET / ORAL | AB | 2012-06-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091220-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091220-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091220-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091220-006 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | 62780d2e-083d-4bcb-99ff-1b1b4ade60d9 | 2026-03-09 | Warnings, Adverse reactions | 091220 ANDA091220 |
| Glimepiride | GLIMEPIRIDE | BluePoint Laboratories | a01b0466-13f5-4c47-ae55-c5f1527d9414 | 2025-07-07 | Warnings, Adverse reactions | 091220 ANDA091220 |
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | d4513181-4558-4d9a-851b-acf7e3eda25a | 2025-06-16 | Warnings, Adverse reactions | 091220 ANDA091220 |
| Glimepiride | GLIMEPIRIDE | Micro Labs Limited | 60e9397e-83b9-489e-9683-6f87e458bbaa | 2025-05-12 | Warnings, Adverse reactions | 091220 ANDA091220 42571-105 |
| Glimepiride 3 mg | GLIMEPIRIDE | Lifsa Drugs LLC | 51157849-7990-4a8b-ae50-eda1baf93cfa | 2024-08-20 | Warnings, Adverse reactions | 091220 ANDA091220 |
| Glimepiride | GLIMEPIRIDE | NCS HealthCare of KY, Inc dba Vangard Labs | 669a67c2-2f97-4b7e-8bba-83a015e0fa94 | 2020-04-30 | Warnings, Adverse reactions | 091220 ANDA091220 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glimepiride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLIMEPIRIDE | 8 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6KY687524K | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 60e9397e-83b9-489e-9683-6f87e458bbaa | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b890b964-2cf0-4439-aaf3-900c9e3e9e49 | Product name | 1 | 20160602 |
| 7611093e-8875-33d4-9e3c-f48c7e3af1e8 | Product name | 1 | 20140508 |
| d36d861f-8a90-80cc-8935-1e6be9b4c7eb | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42571-105-01 | Glimepiride | 100 in 1 BOTTLE | TABLET | 100 | 91233 | |
| 42571-105-05 | Glimepiride | 500 in 1 BOTTLE | TABLET | 500 | 91233 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLIMEPIRIDE | ACTIVE INGREDIENT | 6KY687524K | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| GLIMEPIRIDE | ACTIVE MOIETY | 6KY687524K | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | GLIMEPIRIDE TABLET [MICRO LABS LIMITED] | 91224 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 42571-105-01 | 42571010501 | 100 TABLET in 1 BOTTLE (42571-105-01) | 100 tablet | 2013-06-13 | 0000-00-00 | No | No | Current |
| 42571-105-05 | 42571010505 | 500 TABLET in 1 BOTTLE (42571-105-05) | 500 tablet | 2013-06-13 | 0000-00-00 | No | No | Current |